✦ LIBER ✦

Periodontal Therapy Reduces the Severity of Active Rheumatoid Arthritis in Patients Treated With or Without Tumor Necrosis Factor Inhibitors

✍ Scribed by Ortiz, P.; Bissada, N.F.; Palomo, L.; Han, Y.W.; Al-Zahrani, M.S.; Panneerselvam, A.; Askari, A.

Book ID: 126019157
Publisher: American Academy of Periodontology
Year: 2009
Tongue: English
Weight: 462 KB
Volume: 80
Category: Article
ISSN: 0022-3492
DOI: 10.1902/jop.2009.080447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Periodontal and Serum Protein Profiles i

Periodontal and Serum Protein Profiles in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitor Adalimumab

✍ Kobayashi, Tetsuo; Yokoyama, Tomoko; Ito, Satoshi; Kobayashi, Daisuke; Yamagata, 📂 Article 📅 2014 🏛 American Academy of Periodontology 🌐 English ⚖ 474 KB

Anti-Tumor Necrosis Factor-Alpha Therapy

Anti-Tumor Necrosis Factor-Alpha Therapy and Periodontal Parameters in Patients With Rheumatoid Arthritis

✍ Mayer, Yaniv; Balbir-Gurman, Alexandra; Machtei, Eli E. 📂 Article 📅 2009 🏛 American Academy of Periodontology 🌐 English ⚖ 565 KB

Potentiated Antibodies to Tumor Necrosis

Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis

✍ L. V. Kozlovskaya; N. A. Mukhin; V. V. Rameev; I. A. Sarkisova; O. I. Epstein 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 294 KB

Mortality rates in patients with rheumat

Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: Drug-specific comparisons in the Swedish Biologics Register

✍ Simard, Julia F.; Neovius, Martin; Askling, Johan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Individualized monitoring of drug bioava

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

✍ Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C. Kapetan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## Objective Infliximab, an anti–tumor necrosis factor α (anti‐TNFα) antibody, is effective in the treatment of several immunoinflammatory diseases. However, many patients experience primary or secondary response failure, suggesting that individualization of treatment regimens may be b

Association between the level of circula

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

✍ Hubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Mios 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views